(Albany, New York) – September 24, 2026: (Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Type 2 Diabetes pipeline constitutes 75+ key companies continuously working towards developing 80+
The Key Presbyopia Companies in the market include – AbbVie, Orasis Pharmaceuticals, Eyenovia, Glaukos Corporation, Ocuphire Pharma, Inc., Novartis, Allergan, AbbVie, LENZ Therapeutics, Eyenovia, Visus Therapeutics, and others . The
The Key Respiratory Syncytial Virus Companies in the market include – GlaxoSmithKline, MedImmune, ReViral, Pfizer, Sanofi, BioComo, IMV, Shionogi, Aridis Pharmaceuticals, ADMA Biologics, Enanta Pharmaceuticals, Merck Sharp & Dohme, Janssen
The Key Polycythemia Vera Companies in the market include – Protagonist Therapeutics, Italfarmaco, Imago BioSciences, Silence Therapeutics, Ionis Pharmaceutical, Perseus Proteomics, Protagonist Therapeutics, Inc., Novartis, PharmaEssentia, AOP Orphan Pharmaceuticals AG,
(Albany, New York) – September 24, 2026: As per DelveInsight’s assessment, globally, Diabetic Nephropathy pipeline constitutes 20+ key companies continuously working towards developing 25+ Diabetic Nephropathy treatment therapies, analysis of
(Albany, New York) – September 24, 2026: As per DelveInsight’s assessment, globally, Prostate Cancer pipeline constitutes 140+ key companies continuously working towards developing 150+ Prostate Cancer treatment therapies, analysis of
The Key ARDS Companies in the market include – Light Chain Bio, Direct Biologics, Healios/Nobel Pharma, Mesoblast, Chrysalis BioTherapeutics, Athersys, Inc, Histocell, BioXcellerator, Altor BioScience, Cartesian Therapeutics, Meridigen Biotech Co.,
Fortified Dairy Products Market Size & Trends | Mordor Intelligence Mordor Intelligence has published a new report on the fortified dairy products market, offering a comprehensive analysis of market trends,
The Ulcerative Colitis Clinical Trial Analysis Report delivers important insights into ongoing research of 70+ pipeline Ulcerative Colitis Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) September 24,
The Crohns’ Disease Clinical trial analysis report delivers important insights into ongoing research of 90+ pipeline Crohns’ Disease Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) September 24,
Key Athlete’s Foot companies such as Bausch Health, Blueberry Therapeutics, and others. (Albany, New York) – September 24, 2026 – DelveInsight’s “Athlete’s foot Market Insights, Epidemiology, and Market Forecast – 2034”
Key Atopic Dermatitis companies such as Roche, Eli Lilly and Company, Almirall, Chugai Pharmaceutical, Galderma, Maruho, AbbVie, Pfizer, LEO Pharma, Otsuka Pharmaceutical, Incyte Corporation, Torii Pharmaceutical, Sanofi, Regeneron Pharmaceuticals, and
The market dynamics for Huntington’s Disease are witnessing significant growth driven by the advancements in gene and RNA-based therapies, rising disease awareness and improved diagnostics, strong pipeline of emerging therapies,
The market dynamics for Frontotemporal Dementia are witnessing significant growth driven by the rising prevalence of FTD, increasing disease awareness and diagnosis, growing opportunities in gene therapy, advances in precision
The market dynamics for Esophageal Cancer are witnessing steady growth driven by the rising disease burden and associated risk factors, advancements in multimodal treatment approaches, increasing adoption of immunotherapy and
MCC is a rare, aggressive neuroendocrine skin cancer that originates from Merkel cells, specialized mechanoreceptors located at the dermo-epidermal junction that play a key role in touch sensation, with MCC
Cell and Gene Therapies in Rare Disorders market is undergoing significant transformation as advances in genetic medicine, increasing clinical development activity, regulatory approvals, & the expansion of one-time therapeutic approaches
This report provides detailed insights into the Mydriasis market, including revenue trends, prevalence, and the evolving treatment landscape. It highlights current and projected market sizes, evaluates the efficacy and development
The Radiofrequency Ablation Devices market is estimated at USD 4.35 billion in 2025 and is projected to reach USD 11.27 billion by 2034, growing at a CAGR of 11.23% during
The Insulin Delivery Devices market was valued at USD 20.4 billion in 2025 and is projected to reach USD 42.8 billion by 2034, growing at a CAGR of 8.6% during
